Modification of graft-versus-host disease by neuraminidase treatment of donor cells. Decreased tolerogenicity of neuraminidase-treated cells.
D000818:Animals; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002452:Cell Count; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology* / Q000401:mortality; D006087:Graft vs Host Reaction; D007108:Immune Tolerance; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009439:Neuraminidase / Q000494:pharmacology*; D016038:Skin Transplantation; D013154:Spleen / Q000187:drug effects / Q000637:transplantation*; D014733:Vibrio / Q000201:enzymology
D003520:Cyclophosphamide; D009439:Neuraminidase